MedPath

Local Ketamine Instillation for Postoperative Analgesia

Phase 2
Completed
Conditions
Postoperative Pain
Interventions
Drug: intra-wound instillation of ketamine
Drug: intra-wound instillation of normal saline
Drug: systemic administration of ketamine
Registration Number
NCT02642497
Lead Sponsor
Assiut University
Brief Summary

This study aims at exploring the analgesic efficacy, and safety of Ketamine instillation into the wound of total thyroidectomy compared to placebo,and to systemic ketamine administration (I.M. injection of the same dose) with respect to postoperative VAS, first request of analgesia, total opioid consumption, and with respect to possible side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • patients with thyroid cancer scheduled for total thyroidectomy.
Exclusion Criteria
  1. BMI>35
  2. Unstable ischaemic cardiac disease
  3. Increased intracranial pressure
  4. Increased intraocular pressure
  5. Hypersensitivity or allergy to ketamine, local anesthetic, morphine, or other drugs used in the study.
  6. Severe psychiatric disease
  7. Unwillingness or inability to use PCA-device
  8. Inability to use VAS scale

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
local ketamine groupintra-wound instillation of ketamineintra-wound instillation of ketamine (1 mg/ kg) and normal saline in a total volume of 10 ml dispersed evenly throughout the wound; given after hemostasis and before wound closure, with closure of suction drain tube for 30 min. postoperatively.
control groupintra-wound instillation of normal salineintra-wound instillation of normal saline in a total volume of 10 ml dispersed evenly throughout the wound; given after hemostasis and before wound closure, with closure of suction drain tube for 30 min. postoperatively.
systemic ketamine groupsystemic administration of ketamineIntra-muscular injection of ketamine at a dose of 1 mg/kg before wound closure.
Primary Outcome Measures
NameTimeMethod
total opioid consumption24 hours

the total amount of morphine consumed during follow up period

Secondary Outcome Measures
NameTimeMethod
first request of analgesia24 hours

time to first request of rescue analgesic drug

VAS24 hours

effect of study drugs on postoperative pain measured by VAS score

© Copyright 2025. All Rights Reserved by MedPath